Literature DB >> 18173886

Drug susceptibility profiling of tuberculous meningitis.

S Nagarathna1, W Rafi, H B Veenakumari, R Mani, P Satishchandra, A Chandramuki.   

Abstract

Drug-resistant tuberculosis is an increasing problem worldwide. There are few reports of drug susceptibility patterns of Mycobacterium tuberculosis isolated from cases of tuberculous meningitis. A 5-year retrospective study aimed at analysing the drug susceptibility profile of M. tuberculosis isolated from tuberculous meningitis cases was conducted. A total of 366 isolates were analysed. Among these, 301 (82.2%) were sensitive to all the four primary drugs tested, while 65 (17.8%) showed resistance. There were 46 (12.5%) isolates resistant to isoniazid (INH), while 9 (2.4%) demonstrated multidrug resistance. These data suggest that multidrug resistance in tuberculous meningitis is not yet a serious problem. However, a periodic review is required to ascertain the global incidence of drug-resistant tuberculous meningitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18173886

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

Review 1.  Neurotuberculosis: an update.

Authors:  Ajith Cherian; Kesi Chellappan Ajitha; Thomas Iype; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-05       Impact factor: 2.396

Review 2.  Advances in the Diagnosis and Management of Tubercular Meningitis in Children.

Authors:  Himani Bhasin; Medha Goyal; Suvasini Sharma
Journal:  Indian J Pediatr       Date:  2019-12-04       Impact factor: 1.967

Review 3.  Tuberculosis Meningitis.

Authors:  Kassem Bourgi; Christina Fiske; Timothy R Sterling
Journal:  Curr Infect Dis Rep       Date:  2017-09-11       Impact factor: 3.725

4.  Evaluation of Geno Type MTBDRplus Line Probe Assay for Early Detection of Drug Resistance in Tuberculous Meningitis Patients in India.

Authors:  Renu Gupta; Rajeev Thakur; Prerna Gupta; Nupur Jalan; Suman Kushwaha; Meena Gupta; Piyush Gupta; Amitesh Aggarwal; Vikas Manchanda
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar

5.  Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.

Authors:  Sharada Mailankody; Gurukiran V Dangeti; Rajendiran Soundravally; Noyal M Joseph; Jharna Mandal; Tarun K Dutta; Tamilarasu Kadhiravan
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

6.  Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study.

Authors:  Seniha Senbayrak; Nuri Ozkutuk; Hakan Erdem; Isik Somuncu Johansen; Rok Civljak; Ayse Seza Inal; Uner Kayabas; Ebru Kursun; Nazif Elaldi; Branislava Savic; Soline Simeon; Emel Yilmaz; Olga Dulovic; Derya Ozturk-Engin; Nurgul Ceran; Botond Lakatos; Oguz Resat Sipahi; Mustafa Sunbul; Mucahit Yemisen; Selma Alabay; Bojana Beovic; Aysegul Ulu-Kilic; Yasemin Cag; Melanie Catroux; Asuman Inan; Gorana Dragovac; Ozcan Deveci; Recep Tekin; Hanefi Cem Gul; Gonul Sengoz; Katell Andre; Arjan Harxhi; Yves Hansmann; Serkan Oncu; Sukran Kose; Oral Oncul; Emine Parlak; Alper Sener; Gulden Yilmaz; Umit Savasci; Haluk Vahaboglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-11-04       Impact factor: 3.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.